Clinical Trials Browser

Uterine Neoplasms

NCT07393633 2026-02-10

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Completed

43 enrolled

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms

NCT07382505 2026-02-02

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Not yet recruiting

600 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

NCT06447064 2026-01-15

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT07264660 2025-12-04

Diagnostic Value of Transcervical True-Cut Biopsy in Uterine Masses

Not yet recruiting

42 enrolled

Gynecologic

Uterine Neoplasms

NCT04634617 2025-11-10

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Active not recruiting

310 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT05049538 2025-10-15

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Recruiting

1,000 enrolled

Gynecologic

Uterine Neoplasms

NCT06904365 2025-09-22

OvAR-Y

Recruiting

10 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Uterine Neoplasms

NCT06527157 2025-09-02

PROACTION:

Recruiting

4,500 enrolled

Gynecologic

Uterine Neoplasms

NCT06953076 2025-08-17

MySaturn

Recruiting

111 enrolled

Gynecologic

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

NCT06024109 2025-05-13

BARHYSTER

Recruiting

132 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

NCT03301493 2025-04-10

Genomic Testing and Resulting Medical Decisions

Completed

1,500 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Hematologic Neoplasms

Clinical Trials

(TRUS)

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

(CLOCS-2)

Diagnostic Value of Transcervical True-Cut Biopsy in Uterine Masses

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

OvAR-Y

PROACTION:

MySaturn

BARHYSTER

Genomic Testing and Resulting Medical Decisions